Top 10 Safest Stocks To Own Right Now

Top 10 Safest Stocks To Own Right Now: NeuroMetrix Inc.(NURO)

NeuroMetrix, Inc., a science-based health care company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with diabetes, carpal tunnel syndrome, lumbosacral disc disease, and spinal stenosis. The company focuses on diagnosis and treatment of the neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include the ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the diagnosis and evaluation of CTS, low back and leg pain, and DPN; and the NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care, as well as consumables and accessories for use with its neurodiagnostic equipment. The company is also developing SENSUS pain therapy device, a transcutaneous electrical nerve stimul ator used in the management of chronic pain, such as that caused by DPN; and ADVANCE CTS, a version of the ADVANCE NCS/EMG device for the detection of CTS in people with diabetes. The company distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, and hospitals consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology/podiatry market in the United States and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:

• [By Bryan Murphy]

  My recent love affair with Neurometrix Inc. (NASDAQ:NURO) hasn't exactly been a veiled secret. I first pointed out this diabetes-diagnostics stock was working on a technical breakout effort in early October, and I ! penned two more bullish-progress reports on NURO in November. Yet, the Neurometrix rally is still in its infancy, when you take a step back and look at the bigger weekly chart.

• [By Bryan Murphy]

  Don't get me wrong - it's fun to be right. There's such a thing as being too right (or at least too right, too fast) though, and when that happens, the smart thing to do is, well do something about it. Case in point? I was right yesterday about Neurometrix Inc. (NASDAQ:NURO). I suggested the stock was already in the midst of a breakout, and NURO was poised to soar. I didn't count on this morning's big jump and subsequent gap, however, so now that my risk of continuing to hold it is as big as my potential reward from here, I and anybody else who followed my lead has a tough decision to make... though I've already made mine.

• [By Bryan Murphy]

  If you missed the recent surges from Neurometrix Inc. (NASDAQ:NURO) and/or OXiGENE Inc. (NASDAQ:OXGN), and decided to skip an entry on either or both because they were too frothy at the time, then here's some good news.... you're getting a second chance. Both NURO and OXGN are getting their proverbial second wind, and they're doing so at a price much lower than the price you would have had to pay for either just a few days ago. There's just one catch - you may want to hurry of you want in. This second wind is unfurling as rapidly as the first surges did.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/top-10-safest-stocks-to-own-right-now.html